axicabtagene - Robuta Search

https://adisinsight.springer.com/drugsafety/803702790?error=cookies_not_supported&code=c382bb93-5e17-4351-adf2-cfc52dd8e582 Axicabtagene ciloleucel - AdisInsight In a retrospective study of 19 patients conducted between 2018 and 2020, nine patients [ages and sexes not stated] were described, who developed influenza A, axicabtagene ciloleucel adisinsight https://publikationen.uni-tuebingen.de/xmlui/handle/10900/123703 Fatal late-onset CAR T-cell-mediated encephalitis after axicabtagene-ciloleucel in a patient with... https://digitalcommons.wustl.edu/oa_4/5612/ "Tocilizumab prophylaxis following axicabtagene ciloleucel in relapsed " by Frederick L Locke,... Axicabtagene ciloleucel (axi-cel) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy approved in patients with relapsed/refractory (R/R)... axicabtagene ciloleucel tocilizumab prophylaxis following https://pubmed.ncbi.nlm.nih.gov/39665297/ Correction to "Benefit of Axicabtagene Ciloleucel Versus Chemoimmunotherapy in Older Patients... Correction to "Benefit of Axicabtagene Ciloleucel Versus Chemoimmunotherapy in Older Patients and/or Patients With Poor ECOG Performance Status With Relapsed... axicabtagene ciloleucel correction benefit https://consultqd.clevelandclinic.org/car-t-cell-therapy-with-axicabtagene-ciloleucel CAR T-Cell Therapy with Axicabtagene Ciloleucel ZUMA-7 trial yields practice-changing findings for patients with large B-cell lymphoma who relapse on first-line chemoimmunotherapy. car t cell therapy https://digitalcommons.wustl.edu/oa_4/3523/ "Survival with axicabtagene ciloleucel in large B-cell lymphoma" by Jason R Westin, Armin Ghobadi... BACKGROUND: In an analysis of the primary outcome of this phase 3 trial, patients with early relapsed or refractory large B-cell lymphoma who received... https://adisinsight.springer.com/drugsafety/803438529?error=cookies_not_supported&code=34847b56-b0fc-474b-abd2-1d3cd9b60409 Axicabtagene ciloleucel - AdisInsight A 62-year-old man developed cytokine release syndrome and neurotoxicity manifesting as aphasia, bi-frontal headache, difficulty in following commands, axicabtagene ciloleucel adisinsight